Humanigen Inc (fka HGENQ)

[cowtown jay]

I call the linked peer reviews of our successful Phase III trial successful.

But I also call the PREACH-M trial of lenzilumab's treatment of CMML successful. Once this blazes the pathway of regulatory success for lenz, I think the FDA will recognize the futility of trying to save the covid market for Pfizer. In fact, that's already a lost cause, no matter how much lipstick the FDA puts on the mRNA vaccines. The public is not buying the hype.

But, the public will need a real covid vaccine and covid therapeutic. They will need lenz.

We just need to announce some news, and take an interim step back onto the OTC pink venue.